+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sclerotherapy Market by Type, Product, Application, End User - Global Forecast to 2030- Product Image
Sclerotherapy Market by Type, Product, Application, End User - Global Forecast to 2030- Product Image
Sale

Sclerotherapy Market by Type, Product, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083469
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sclerotherapy market is evolving rapidly, driven by technological innovation, refined clinical applications, and increased preference for minimally invasive solutions among healthcare providers. Senior decision-makers are seeking insights into the intersection of technology, cost pressures, and global growth as they navigate procurement, R&D investments, and competitive strategy within the sclerotherapy sector.

Market Snapshot: Sclerotherapy Market Size and Growth

The sclerotherapy market grew from USD 803.02 million in 2024 to USD 852.41 million in 2025. It is expected to continue growing at a CAGR of 6.47%, reaching USD 1.17 billion by 2030. This performance reflects the sector’s expanding clinical usage, diversified applications, and dynamic competitive landscape.

Scope & Segmentation

This market research delves into a structured analysis encompassing advanced procedure types, evolving technologies, and global regional trends.

  • Type: Foam Sclerotherapy, Liquid Sclerotherapy, Ultrasound Sclerotherapy
  • Product: Equipment, Sclerosants (Chemical Irritants, Detergents, Osmotic Agents)
  • Application: Hemorrhoids, Lymphatic Malformations, Varicose Veins
  • End User: Ambulatory Surgery Centers, Dermatology & Cosmetic Centers, Hospitals
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including Western and Eastern European countries, GCC, and African markets), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia)
  • Leading Companies: 3M Company, Abbott Laboratories, AccuVein, Inc., Angiodynamics Inc., B. Braun Melsungen AG, Biolitec AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, BTG International Ltd., Chemische Fabrik Kreussler & Co. GmbH, Cook Medical Inc., DJO Global, Inc., Endo-Med Technologies Pvt. Ltd., Ethicon Inc. by Johnson & Johnson Services Inc., Inari Medical, Inc., Medtronic PLC, Merz Pharma GmbH & Co. KGaA, Rex Medical LP, Sanofi S.A., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Teva Pharmaceutical Company, Vascular Solutions, Inc., Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Foam agents are increasingly favored for treating larger venous lesions, while liquid and ultrasound-guided sclerotherapy remain valuable in specialized or superficial scenarios.
  • Novel sclerosant formulations and advanced imaging are enhancing procedural precision and patient outcomes, prompting device and pharmaceutical suppliers to invest in R&D partnerships for integrated platforms.
  • Global demand is rising across both developed and emerging markets, fueled by aging populations, greater outpatient procedure volumes, and broader reimbursement options.
  • Customization is key: End users seek modular systems that adapt to diverse patient profiles, complemented by robust clinician training initiatives from manufacturers or distributors.
  • Diversified supply chains and regional distribution are central to sustaining product access amid regulatory shifts and trade realignments.
  • Increasing focus on outpatient care and cost management is steering the adoption of value-based procurement strategies across ambulatory surgery centers and high-volume hospital networks.

Tariff Impact on Market Dynamics

Recent US tariff changes have introduced new challenges for both equipment manufacturers and pharmaceutical suppliers within the sclerotherapy sector. Manufacturers have reassessed sourcing plans and, in some cases, localized production to minimize import duties, which has caused temporary supply constraints. Pharmaceutical distributors have responded by renegotiating logistics contracts and revisiting cost structures, some of which have been transferred to healthcare providers. These shifts have led practices to re-evaluate product choices and procurement timing, influencing ongoing budget and supply chain strategies.

Sclerotherapy Market Research Methodology & Data Sources

This analysis integrates primary interviews with vascular care professionals alongside a thorough review of clinical literature, regulatory filings, and industry reports. Quantitative findings rely on cross-referenced government data and leading provider purchase records. Rigorous data validation, outlier detection, and dynamic segmentation models support the credibility of trends and strategic recommendations.

Why This Report Matters

  • Gain actionable intelligence on the intersection of emerging technologies and shifting reimbursement policies to inform procurement, portfolio development, and ROI initiatives.
  • Understand nuanced regional trends and evolving end-user requirements for targeted market entry or expansion.
  • Leverage competitive benchmarking across leading manufacturers and suppliers for strategic planning and partnership development.

Conclusion

This report provides a strategic, data-driven overview of the sclerotherapy market for senior decision-makers. Equipped with insights into evolving technologies, procurement dynamics, and regional trends, stakeholders can confidently pursue new opportunities and achieve sustained growth.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sclerotherapy Market, by Type
8.1. Introduction
8.2. Foam Sclerotherapy
8.3. Liquid Sclerotherapy
8.4. Ultrasound Sclerotherapy
9. Sclerotherapy Market, by Product
9.1. Introduction
9.2. Equipment
9.3. Sclerosants
9.3.1. Chemical Irritants
9.3.2. Detergents
9.3.3. Osmotic Agents
10. Sclerotherapy Market, by Application
10.1. Introduction
10.2. Hemorrhoids
10.3. Lymphatic Malformations
10.4. Varicose Veins
11. Sclerotherapy Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Dermatology & Cosmetic Centers
11.4. Hospitals
12. Americas Sclerotherapy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Sclerotherapy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Sclerotherapy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 3M Company
15.3.2. Abbott Laboratories
15.3.3. AccuVein, Inc.
15.3.4. Angiodynamics Inc.
15.3.5. B. Braun Melsungen AG
15.3.6. Biolitec AG
15.3.7. BIOTRONIK SE & Co. KG
15.3.8. Boston Scientific Corporation
15.3.9. BTG International Ltd.
15.3.10. Chemische Fabrik Kreussler & Co. GmbH
15.3.11. Cook Medical Inc.
15.3.12. DJO Global, Inc.
15.3.13. Endo-Med Technologies Pvt. Ltd.
15.3.14. Ethicon Inc. by Johnson & Johnson Services Inc.
15.3.15. Inari Medical, Inc.
15.3.16. Medtronic PLC
15.3.17. Merz Pharma GmbH & Co. KGaA
15.3.18. Rex Medical LP
15.3.19. Sanofi S.A.
15.3.20. Smith & Nephew PLC
15.3.21. Stryker Corporation
15.3.22. Teleflex Incorporated
15.3.23. Terumo Corporation
15.3.24. Teva Pharmaceutical Company
15.3.25. Vascular Solutions, Inc.
15.3.26. Viatris Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SCLEROTHERAPY MARKET MULTI-CURRENCY
FIGURE 2. SCLEROTHERAPY MARKET MULTI-LANGUAGE
FIGURE 3. SCLEROTHERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SCLEROTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SCLEROTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SCLEROTHERAPY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SCLEROTHERAPY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SCLEROTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SCLEROTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SCLEROTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SCLEROTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SCLEROTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SCLEROTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SCLEROTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SCLEROTHERAPY MARKET SIZE, BY FOAM SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SCLEROTHERAPY MARKET SIZE, BY LIQUID SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SCLEROTHERAPY MARKET SIZE, BY ULTRASOUND SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SCLEROTHERAPY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SCLEROTHERAPY MARKET SIZE, BY CHEMICAL IRRITANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SCLEROTHERAPY MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SCLEROTHERAPY MARKET SIZE, BY OSMOTIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SCLEROTHERAPY MARKET SIZE, BY HEMORRHOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SCLEROTHERAPY MARKET SIZE, BY LYMPHATIC MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SCLEROTHERAPY MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SCLEROTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SCLEROTHERAPY MARKET SIZE, BY DERMATOLOGY & COSMETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SCLEROTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES SCLEROTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. CANADA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 40. CANADA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. GERMANY SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. GERMANY SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 71. GERMANY SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. GERMANY SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. FRANCE SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. FRANCE SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. FRANCE SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 76. FRANCE SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. FRANCE SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. ITALY SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ITALY SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. ITALY SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 86. ITALY SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ITALY SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SPAIN SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 91. SPAIN SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SPAIN SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. DENMARK SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. DENMARK SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 111. DENMARK SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. QATAR SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 121. QATAR SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. FINLAND SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. FINLAND SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 126. FINLAND SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FINLAND SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. EGYPT SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. TURKEY SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. TURKEY SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 146. TURKEY SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. TURKEY SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. NORWAY SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 156. NORWAY SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. NORWAY SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. POLAND SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. POLAND SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. POLAND SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 161. POLAND SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. POLAND SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. CHINA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 177. CHINA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. CHINA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. INDIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. INDIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. INDIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 182. INDIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. INDIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. JAPAN SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. JAPAN SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. JAPAN SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 187. JAPAN SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. THAILAND SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. THAILAND SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 207. THAILAND SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. THAILAND SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN SCLEROTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN SCLEROTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN SCLEROTHERAPY MARKET SIZE, BY SCLEROSANTS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN SCLEROTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN SCLEROTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SCLEROTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. SCLEROTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sclerotherapy market report include:
  • 3M Company
  • Abbott Laboratories
  • AccuVein, Inc.
  • Angiodynamics Inc.
  • B. Braun Melsungen AG
  • Biolitec AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Chemische Fabrik Kreussler & Co. GmbH
  • Cook Medical Inc.
  • DJO Global, Inc.
  • Endo-Med Technologies Pvt. Ltd.
  • Ethicon Inc. by Johnson & Johnson Services Inc.
  • Inari Medical, Inc.
  • Medtronic PLC
  • Merz Pharma GmbH & Co. KGaA
  • Rex Medical LP
  • Sanofi S.A.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Teva Pharmaceutical Company
  • Vascular Solutions, Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 852.41 Million
Forecasted Market Value ( USD ) by 2030 $ 1170 Million
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Disposable Sclerotherapy Needle Market by Application, Gauge Size, End Use, Distribution Channel, Material, Packaging Type, Technique, Sterilization - Global Forecast to 2030 - Product Image

Disposable Sclerotherapy Needle Market by Application, Gauge Size, End Use, Distribution Channel, Material, Packaging Type, Technique, Sterilization - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Sclerotherapy Market Size, Share & Trends Analysis Report By Agents, By Type, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sclerotherapy Market Size, Share & Trends Analysis Report By Agents, By Type, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
2024 Global Forecast for Sclerotherapy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Sclerotherapy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. Edition No. 6 - Product Image

Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. Edition No. 6

  • Book

About the Sclerotherapy Market

Sclerotherapy is a medical procedure used to treat varicose veins and spider veins. It involves injecting a solution into the affected veins, which causes them to collapse and eventually disappear. The procedure is minimally invasive and can be performed in a doctor's office. It is often used as an alternative to more invasive surgical procedures, such as vein stripping or laser ablation. Sclerotherapy is a popular treatment option for those suffering from varicose veins and spider veins. It is relatively safe and effective, and can be performed quickly and with minimal discomfort. The procedure is often covered by insurance, making it an affordable option for many patients. There are a number of companies that offer sclerotherapy products and services. These include Sclerotherapy Solutions, Vein Solutions, and Vein Care. Other companies, such as Medtronic and Covidien, offer sclerotherapy products as part of their larger portfolio of medical devices. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.